Regeneron Pharmaceuticals, Inc

Biotechnology
REGN
$ 705 1.5
Share price
$ 77 bn
Market Cap
$ 70 bn
Enterprise Value

Carbon footprint

1.3 Ton
GHG emissions per $ 1 mln investment
0.03x the weighted average for S&P 500
FY2021
How is this calculated?
+14%
YOY change in GHG emissions
Stronger than the +4.9% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Regeneron Pharmaceuticals, Inc's GHG emissions (market-based) (Kt of CO2e)
Regeneron Pharmaceuticals, Inc's Carbon intensity (Tons per 1 USDm)

Regeneron Pharmaceuticals, Inc's carbon footprint

Regeneron Pharmaceuticals, Inc reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 92 Kt (+11/+14% y-o-y). At the sime time, carbon intensity tumbled to 5.7 t (-3.8 /-40% y-o-y).

Regeneron Pharmaceuticals, Inc's Scope 3 emissions grew to 822 Kt (+53/+6.9% y-o-y). The growth rate declined vs. the previous periods (CAGR +24% since 4Q'17).

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Company environmental metrics

Show more...